• Genotyping Kit for Target Alleles: Rapid, Single-Tube DNA Pr

  2026-04-20

  The Genotyping Kit for target alleles of insects, tissues, fishes and cells delivers streamlined, phenol-free DNA prep and robust PCR in a single tube, accelerating workflows and minimizing contamination. Its rapid, extraction-free protocol empowers high-throughput molecular biology genotyping research across diverse sample types.

• Structural Innovation in Degarelix Analogs: Impact on GnRH A

  2026-04-19

  This study explores the synthesis and activity of degarelix analogs modified with 3-(2-methoxy-5-pyridyl)-alanine at position 3, revealing critical structure-activity relationships in GnRH receptor antagonists. The findings inform the design of next-generation hormone therapies and highlight stereochemistry as a determinant of antagonist potency.

• Coronavirus Macrodomain: Essential for Counteracting PARP Re

  2026-04-18

  This study demonstrates that the coronavirus macrodomain is required to overcome poly (ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and enhancement of interferon (IFN) expression. By dissecting the interplay between viral macrodomains and host PARPs such as PARP12 and PARP14, the research clarifies mechanisms of viral immune evasion and highlights new antiviral targets.

• IPA-3: Applied Pak1 Inhibition for Kinase Assays & Recovery

  2026-04-17

  IPA-3, a selective Pak1 inhibitor, empowers researchers to dissect kinase signaling with unmatched precision and supports rigorous workflows in cancer biology and neuroinflammation research. This article delivers stepwise protocols, troubleshooting strategies, and cross-domain insights for advanced experimental designs.

• DMH1: A Precise ALK2 Inhibitor for Organoid & NSCLC Research

  2026-04-16

  DMH1 delivers unrivaled selectivity for ALK2, enabling researchers to finely modulate BMP signaling in both advanced organoid models and non-small cell lung cancer (NSCLC) studies. Its robust performance in controlling Smad1/5/8 phosphorylation and Id gene expression makes it a leading tool for high-fidelity disease modeling, cell differentiation, and cancer pathway interrogation.

• Rhodamine B in Environmental Tracing: Advanced Assay Precisi

  2026-04-15

  Explore how Rhodamine B (Basic Violet 10) enables next-generation environmental tracing and drift quantification, with deep protocol insights and critical reference analysis. Discover how this fluorescent probe elevates accuracy beyond cell assays.

• NF 340: Potent P2Y11 Antagonist for GPCR Signaling Research

  2026-04-14

  NF 340 is a highly selective P2Y11 antagonist enabling precise modulation of GPCR signaling in immunology and inflammation research. Recent studies confirm its efficacy in reversing QPRT-driven cancer invasiveness. Its robust performance and chemical stability make it a trusted tool for dissecting purinergic pathways.

• Sulfo-NHS-SS-Biotin: Elevating Protein Labeling for Purifica

  2026-04-13

  Sulfo-NHS-SS-Biotin is transforming surface protein labeling with its cleavable, water-soluble design—ideal for affinity purification and reversible capture workflows. This guide translates current research and expert protocols into actionable steps, troubleshooting insights, and comparative advantages for biochemists seeking precision and reproducibility.

• Hyperthermia–Cisplatin Synergy: Caspase-8 Activation in Canc

  2026-04-12

  This study investigates how combining hyperthermia with cisplatin chemotherapy leads to enhanced apoptosis and pyroptosis in cancer cells via caspase-8 accumulation and activation. The work advances our understanding of caspase-8–mediated cell death mechanisms, with practical implications for optimizing programmed cell death research and related assay methodologies.

• Dimethyloxalylglycine (DMOG): Technical Use in Hypoxia Studi

  2026-04-12

  Dimethyloxalylglycine (DMOG) enables precise, reversible stabilization of hypoxia-inducible factors in cell and animal models, facilitating controlled investigation of hypoxia signaling and inflammation. It is unsuitable for diagnostic or clinical applications and should not be used where mechanistic ambiguity or off-target effects are unacceptable.

• LY294002: Precision PI3K/Akt/mTOR Inhibition for Cancer Rese

  2026-04-11

  LY294002 stands out as a benchmark PI3K/Akt/mTOR signaling pathway inhibitor with robust, reproducible performance in cell-based and in vivo oncology workflows. This article delivers actionable guidance on leveraging its strengths, troubleshooting common experimental pitfalls, and translating PI3K pathway insights from bench to advanced cancer models.

• c-Myc tag Peptide: Precision Tool for Fusion Protein Displac

  2026-04-11

  The c-Myc tag Peptide unlocks high-specificity displacement of c-Myc-tagged fusion proteins, enhancing immunoassay selectivity and reproducibility. By leveraging its unique solubility and inhibition profile, researchers can fine-tune workflows in cancer biology and transcription factor studies. Explore advanced troubleshooting strategies and protocol refinements that set APExBIO's c-Myc tag Peptide apart as a trusted research reagent.

• Olaparib (AZD2281): Selective PARP Inhibitor for BRCA-Def...

  2026-04-10

  Olaparib (AZD2281) stands out as a selective PARP-1/2 inhibitor, empowering cancer researchers to dissect DNA repair mechanisms and overcome resistance in BRCA-deficient models. This guide delivers actionable workflows, troubleshooting insights, and advanced applications that maximize reproducibility and translational impact in DNA damage response and tumor radiosensitization studies.

• Perphenazine: Dopamine D2 Receptor Antagonist for Neuroph...

  2026-04-09

  Perphenazine is a dopamine D2 receptor antagonist with a well-characterized multi-receptor binding profile, validated for neuropharmacology research and host-pathogen interaction studies. Its robust induction of mitochondria-mediated cell death and emerging role in host-directed antibacterial strategies position it as a versatile research tool.

• Benzyl Quinolone Carboxylic Acid: Precision M1 Muscarinic...

  2026-04-08

  Benzyl Quinolone Carboxylic Acid (BQCA) is a highly selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor, enabling precise dissection of cholinergic signaling in cognitive and Alzheimer’s disease models. This guide delivers actionable workflows, advanced troubleshooting, and comparative insights, empowering researchers to maximize reproducibility and translational relevance in neuroscience studies.

451 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page